Ani Pharmaceuticals (ANIP) Tops Q1 EPS by 1c

Ani Pharmaceuticals (NASDAQ: ANIP) reported Q1 EPS of $0.33, $0.01 better than the analyst estimate of $0.32. Revenue for the quarter came in at $10.9 million versus the consensus estimate of $11.4 million.

For earnings history and earnings-related data on Ani Pharmaceuticals (ANIP) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Empress Royalty acquires Tongon gold stream for $62M
• Could Affirm be a $200 stock?